๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The expression of CD44 adhesion molecules on seminoma cells: A new marker for early detection of the tumor

โœ Scribed by Faruk Hadziselimovic; Bruno Herzog; Lyman R. Emmons


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
117 KB
Volume
77
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


he incidence of seminoma in Stage I and Stage I1 was assessed in T a large population. A testicular biopsy was obtained from infertile males and from cryptorchid boys who had undergone a corrective surgical procedure. In no patient was a tumor suspected. The tissue was embedded in Epon and semithin sections were analyzed histochemically with a light microscope. A total of 4746 biopsies were analyzed by the same investigator. The seminomatous tumor was confirmed by two methods: its typical histologic ultrastructural morphology,' and with immunohistochemical techniques employing a specific antiseminoma monoclonal antibody [YLEM:CVA512] .2 All together, 9 seminomas were found in 4084 patients. One of these patients subsequently developed seminomas in both testes.


๐Ÿ“œ SIMILAR VOLUMES


IL-12- and IL-2-induced tumor regression
โœ Giovana R. Thomas; Zhong Chen; Ileana Enamorado; Caren Bancroft; Carter Van Waes ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 313 KB ๐Ÿ‘ 1 views

Therapy with IL-12 or IL-2 induces tumor regression in only a few patients with head-and-neck squamous cell carcinoma (SCC), and the factors promoting responsiveness have not been well defined. In this study, we examined whether combined IL-12 and IL-2 therapy can induce tumor regression in a new mu

Expression of CD134 (0X-40) on T cells d
โœ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 225 KB ๐Ÿ‘ 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4ุ‰ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets